Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009

被引:0
作者
Maura Pugliatti
Leslie D. Parish
Paola Cossu
Stefania Leoni
Anna Ticca
M. Valeria Saddi
Enzo Ortu
Sebastiano Traccis
Giuseppe Borghero
Roberta Puddu
Adriano Chiò
Pietro Pirina
机构
[1] Università degli Studi di Sassari,Dip. di Medicina Clinica e Sperimentale, Neurologia
[2] “S. Francesco” Hospital,Division of Neurology
[3] “A. Segni” Hospital,Division of Neurology
[4] Azienda Ospedaliero-Universitaria di Cagliari and University of Cagliari,Department of Neuroscience
[5] University of Turin,Department of Clinical and Experimental Medicine, Lung Disorders
[6] University of Sassari,undefined
来源
Journal of Neurology | 2013年 / 260卷
关键词
Amyotrophic lateral sclerosis; Motor neuron disease; Incidence; Prevalence; Survival; Sardinia;
D O I
暂无
中图分类号
学科分类号
摘要
Recent genetic studies suggest a Sardinian type of amyotrophic lateral sclerosis (ALS). Thus, ALS incidence, prevalence and survival were investigated in a large population of Sardinians aimed to disclose population-specific patterns and their temporal changes. This is a population-based incidence and prevalence study in northern and central Sardinia, insular Italy (over 700,000 population). Incidence rates were computed for the time interval 1995–2009 and by quinquennia. Prevalence was computed for prevalence days 31 December 2004 and 2009. Onset-based survival for 1995–2009 is also reported. All ALS patients (El Escorial Criteria) in the study area were retrospectively included. The ALS crude incidence from 2005–2009 was 2.5 (95 % CIs: 0.1, 4.9), 3.4 in men and 1.6 in women. Onset occurred most often between the age of 65–74 years in men and 55–64 years in women. The ALS incidence tended to increase over the period 1995–2009. The mean age at onset was 61.7 years with no difference based on gender, varying significantly from 59.9 years in 1995–1999 to 63.9 years in 2005–2009. On December 31, 2009, the ALS crude prevalence was 10.8 per 100,000 (95 % CIs: 8.6, 13.1), 13.8 in men and 8.0 in women, whereas it was 6.3 per 100,000 (95 % CIs: 4.1, 8.6) on December 31, 2004 (M:F ratio of 0.95). Mean survival from onset was 37.0 months, with no difference based on gender, and a tendency to decrease during the period 1995–2009, in relation to type and age of onset. The population-based incidence and prevalence data of ALS in Sardinians indicate an increase of the disease occurrence over the past 40 years, providing support for a population-specific variant of ALS in Sardinia.
引用
收藏
页码:572 / 579
页数:7
相关论文
共 132 条
[1]  
Rowland LP(2001)Amyotrophic lateral sclerosis N Engl J Med 344 1688-1700
[2]  
Shneider NA(2011)Large proportion of amyotrophic lateral sclerosis cases in sardinia due to a single founder mutation of the TARDBP gene Arch Neurol 68 594-598
[3]  
Chiò A(2012)The C9ORF72 expansion mutation is a common cause of ALS+/− FTD in Europe and has a single founder Eur J Hum Genet 72 245-256
[4]  
Borghero G(2011)Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 72 257-268
[5]  
Pugliatti M(2011)A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 11 323-330
[6]  
Smith BN(2012)Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study Lancet Neurol 83 730-733
[7]  
Newhouse S(2012)ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations J Neurol Neurosurg Psychiatry 33 1848.e15-1848.e20
[8]  
Shatunov A(2012)C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population Neurobiol Aging 81 385-390
[9]  
DeJesus-Hernandez M(2010)Incidence of amyotrophic lateral sclerosis in Europe J Neurol Neurosurg Psychiatry 36 883-892
[10]  
Mackenzie IR(1993)A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group Diabetologia 14 294-303